A potential role for gap junctions in breast cancer metastasis to bone

Journal of Musculoskeletal Neuronal Interactions

Volumn 3, Issue 2, 2003, Pages 156-161

  Donahue, Henry J ^a   Saunders, M M ^a   Li, Z ^a   Mastro, A M ^b   Gay, C V ^b   Welch, D R ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GAP JUNCTION PROTEIN; MYOSIN LIGHT CHAIN KINASE;

ARTICLE; BONE MATRIX; BONE METASTASIS; BREAST CANCER; CALCIUM MOBILIZATION; CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL MIGRATION; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM; ENZYME ACTIVATION; GAP JUNCTION; HUMAN; HUMAN CELL; HYPOTHESIS; OSTEOBLAST; PROTEIN EXPRESSION;

EID: 0043173748     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Walther HE. Krebsmetastasen. Bens schwabe verlag. Basel, Switzerland; 1948.
2. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80(Suppl.8):1529-1537.
3. Mundy GR. Mechanisms of bone metastasis. Cancer 1997; 80(Suppl.8):1546-1556.
4. Goltzman D. Mechanisms of the development of osteoblastic metastases. Cancer 1997; 80(Suppl.8):1581-1587.
5. Paget J. The distribution of secondary growths in cancer of the breast. Lancet 1889; i:571-573.
6. Chole RA, Tinling SP. Bone lining cells of the mammalian cochlea. Hear Res 1994; 75:233-243.
7. Dodds PR, Caride VJ, Lytton B. The role of vertebral veins in the dissemination of prostatic carcinoma. J Urol 1981; 126:753-755.
8. Galasko CS. Skeletal metastases. Clin Orthop Rel Res 1986; 210:18-30.
9. Galasko C. Skeletal metastases. Butterworth, London; 1986:1-160.
10. Trosko J, Ruch R. Cell-cell communication in carcinogenesis. Front Biosci 1998; 3:D208-236.
11. Brauner T, Hulser DF. Tumor cell invasion and gap junctional communication. II. Normal and malignant cells confronted in multicell spheroids. Invasion Metastasis 1990; 10:31-48.
12. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 1999; 59:4104-4110.
13. El-Sabban ME, Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatic cancer cells and endothelium. Invasion Metastasis 1994; 14:164-176.
14. Brauner T, Schmid A, Hulser DF. Tumor cell invasion and gap junctional communication. I. Normal and malignant cells confronted in monolayer cultures. Invasion Metastasis 1990; 10:18-30.
15. Donahue HJ, McLeod KJ, Rubin CT, Andersen J, Grine EA, Hertzberg EL, Brink PR. Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res 1995; 10:881-889.
16. Donahue HJ, Li Z, Zhou Z, Yellowley CE. Differentiation of human fetal osteoblastic cells is partially dependent on gap junctional intercellular communication. Am J Physiol Cell Physiol 2000; 278:C315-C322.
17. Civitelli R, Beyer EC, Warlow PM, Robertson AJ, Geist ST, Steinberg TH. Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J Clin Invest 1993; 91:1888-1896.
18. Koval M, Harley JE, Hick E, Steinberg TH. Connexin46 is retained as monomers in a trans-Golgi compartment of osteoblastic cells. J Cell Biol 1997; 137:847-857.
19. Monaghan P, Clarke C, Perusinghe NP, Moss DW, Chen XY, Evans WH. Gap junction distribution and connexin expression in human breast. Exp Cell Res 1996; 223:29-38.
20. Locke D, Perusinghe N, Newman T, Jayatilake H, Evans WH, Monaghan P. Developmental expression and assembly of connexins into homomeric and heteromeric gap junction hemichannels in the mouse mammary gland. J Cell Physiol 2000; 183:228-237.
21. Jamieson S, Going JJ, Arcy RD, George WD. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumors. J Pathol 1998; 184:37-43.
22. Pozzi A, Risek B, Kiang DT, Gilula NB, Kumar NM. Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 1995; 220:212-219.
23. Wilgenbus KY, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 1992; 51:522-529.
24. Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 1966; 209:1248-1249.
25. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 1991; 88:10701-10705.
26. Locke D. Gap junctions in normal and neoplastic mammary gland. J Pathol 1998; 186:343-349.
27. Asamoto M, Takahashi S, Imaida K, Shirai T, Fukushima S. Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis. Carcinogenesis 1994; 15:2163-2166.
28. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999; 18:15-30.
29. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994; 1198:11-26.
30. Bracke ME, Van Roy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 1996; 213(Pt 1):123-161.
31. Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12:226-237.
32. Kanno Y, Sasaki Y, Shiba Y, Yoshida-Noro C, Takeichi M. Monoclonal antibody ECCD-1 inhibits intercellular communication in teratocarcinoma PCC3 cells. Exp Cell Res 1984; 152:270-274.
33. Jongen WMF, Fitzgerald DJ, Asamoto M, Piccoli C, Slaga TJ, Gros D, Takeichi M, Yamasaki H. Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J Cell Biol 1991; 114:545-555.
34. Prowse DM, Cadwallader GP, Pitts JD. E-cadherin expression can alter the specificity of gap junction formation. Cell Biol Int 1997; 21:833-843.
35. Terzaghi-Howe M, Chang GW, Popp D. Emergence of undifferentiated rat tracheal cell carcinomas, but not squamous cell carcinomas, is associated with a loss of expression of E-cadherin and of gap junction communication. Carcinogenesis 1997; 18:2043-2050.
36. Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000; 60:2764-2769.
37. Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, Donahue HJ. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001; 61:1765-1767.
38. Umhauer S, Ruch RJ, Fanning J. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 2000; 182:999-1000.
39. Rosenkranz HS, Pollack N, Cunningham AR. Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena. Carcinogenesis 2000; 21:1007-1011.
40. Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Zaidan-Dagli ML, Omori Y. Role of connexin (gap junction) genes in cell growth control and carcinogenesis. CR Acad Sci III, 1999; 322:151-159.
41. Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 2000; 18:683-693.
42. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002; 273:229-239.
43. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994; 56:87-94.
44. Sandig M, Voura EB, Kalnins VI, Siu CH. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton 1997; 38:351-364.
45. El-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 1991; 115:1375-1381.
46. Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 1988; 948:175-224.
47. 2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration. Clin Exp Metastasis 1998; 16:21-29.
48. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993; 120:1371-1380.
49. Ziegelstein RC, Corda S, Pili R, Passaniti A, Lefer D, Zweier JL, Fraticelli A, Capogrossi MC. Initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store. Circulation 1994; 90:1899-1907.
50. Pfau S, Leitenberg D, Rinder H, Smith BR, Pardi R, Bender JR. Lymphocyte adhesion-dependent calcium signaling in human endothelial cells. J Cell Biol 1995; 128:969-978.
51. 2+ increases upon tumor cell contact and modulates cell-cell adhesion. J Clin Invest 1993; 92:3017-3022.
52. Boitano S, Dirksen ER, Sanderson MJ. Intercellular propagation of calcium waves mediated by inositol trisphosphate. Science 1992; 258:292-295.
53. 2+ in epithelial cells. Cell Regul 1990; 1:585-596.
54. Yellowley CE, Li Z, Zhou Z, Jacobs CR, Donahue HJ. Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res 2000; 15:209-217.
55. Yohem KH, Clothier JL, Montague SL, Geary RJ, Winters ALD, Hendrix MJ, Welch DR. Inhibition of tumor cell invasion by verapamil. Pigment Cell Res 1991; 4:225-233.
56. Lin P, Luby-Phelps K, Stull JT. Properties of filament-bound myosin light chain kinase. J Biol Chem 1999; 274:5987-5994.
57. Stull JT, Lin PJ, Krueger JK, Trewhella J, Zhi G. Myosin light chain kinase: functional domains and structural motifs. Acta Physiol Scand 1998; 164:471-482.
58. Kohama K, Ye LH, Hayakawa K, Okagaki T. Myosin light chain kinase: an actin-bindinig protein that regulates an ATP-dependent interaction with myosin. Trends Pharmacol Sci 1996; 17:284-287.
59. Garcia JG, Verin AD, Herenyiova M, English D. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J Appl Physiol 1998; 84:1817-1821.